Anzeige
+++100%-Trefferquote des Nachbarn: JETZT WIRD GEBOHRT! Genau jetzt könnten bei dieser Aktie exponentielle Gewinne erzielt werden JETZT WIRD GEBOHRT! Genau jetzt könnten bei dieser Aktie exponentielle Gewinne erzielt werden+++
EQS-News

BIO-Europe Spring® 2024 returns to Barcelona 13.02.2024, 10:00 Uhr von EQS News Jetzt kommentieren: 0

EQS-News: EBD Group / Key word(s): Conference
BIO-Europe Spring® 2024 returns to Barcelona

13.02.2024 / 10:00 CET/CEST
The issuer is solely responsible for the content of this announcement.


BIO-Europe Spring® 2024 returns to Barcelona

MUNICH, GERMANY – February 13, 2024. The eighteenth annual BIO-Europe Spring®, the premier springtime partnering conference, will take place March 18–20, 2024 in Barcelona, Spain. After remarkable attendance in Basel last year, the event will continue to build on its growth trajectory.

Building and nurturing relationships is an essential part of the progression of successful business partnerships. Especially for innovative biotech companies, a collaborative approach to asset development is key. BIO-Europe Spring is the premier event that connects the global biopharma community in the first part of the year to elevate life science partnerships.

Expanding on the success of EBD Group’s flagship conference, BIO-Europe®, BIO-Europe Spring will bring together over 3,700 leading executives from around the world. Specifically, we will host more than 20,000 partnering meetings to connect leaders from academia, startups, and scaling biotech companies with forward-thinking investors and pharma companies. Along with world-class workshops and panels, innovative company presentations, an active exhibition, and a variety of networking opportunities make this event an unrivalled forum for companies across the biotech value chain to meet and do business.

EBD Group’s partnering platform, partneringONE™, is now open to start requesting priority meetings. Using ONE login, delegates can experience the entire event from anywhere, including one-to-one meetings and conference activities. Scheduled meetings will take place face-to-face during the conference days as well as digitally during the digital partnering days (March 26-27, 2024) with links to a video conferencing solution. Additionally, on-demand content will be made available leading up to the event as well as during the digital days.

Together with the Biotechnology Innovation Organization (BIO), EBD Group is thrilled to welcome you back to this “must-attend” springtime partnering event—making it a special reunion for some and new beginnings for others.

Registration information for BIO-Europe Spring is available online. Discounted rates are available until March 5.

For more information, please visit the conference website at: https://informaconnect.com/bioeurope-spring

Additional links and information:

Follow BIO-Europe Spring 2024 on X @EBDGroup (hashtag: #BIOEuropeSpring) or on LinkedIn.

About EBD Group

EBD Group’s overriding mission is to help collaborations get started across the life science value chain. Our range of partnering conferences has grown to become the largest and most productive conference platform in the industry. Each one of our landmark events held in key life science markets around the world is powered by our state-of-the-art partnering software, partneringONE®, that enables delegates to efficiently identify and engage with new opportunities via one-to-one meetings. Today our events (BIO-Europe®, BIO-Europe Spring®, Biotech Showcase™, ChinaBio® Partnering Forum, Asia Bio Partnering Forum and BioEquity Europe) annually attract more than 15,000 senior life science executives who engage in over 50,000 one-to-one partnering meetings. These vital one-to-one engagements are the wellspring of deals that drive innovation in our industry. EBD Group is an Informa company. For more information, please visit www.ebdgroup.com.

Media Contacts:

MC Services AG
+49 89 2102280
contact@mc-services.eu 

Guadalupe Rodriguez
EBD Group
grodriguez@ebdgroup.com



13.02.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


1835711  13.02.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1835711&application_name=news&site_id=boersennews
Kommentare (0) ... diskutiere mit.
Werbung

Handeln Sie Aktien bei SMARTBROKER+ für 0 Euro!* Profitieren Sie von kostenloser Depotführung, Zugriff auf 29 deutsche und internationale Börsenplätze und unschlagbar günstigen Konditionen – alles in einer innovativen, brandneuen App. Jetzt zu SMARTBROKER+ wechseln und durchstarten!

*Ab 500 EUR Ordervolumen über gettex. Zzgl. marktüblicher Spreads und Zuwendungen.

k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
Schreib den ersten Kommentar!

Dis­clai­mer: Die hier an­ge­bo­te­nen Bei­trä­ge die­nen aus­schließ­lich der In­for­ma­t­ion und stel­len kei­ne Kauf- bzw. Ver­kaufs­em­pfeh­lung­en dar. Sie sind we­der ex­pli­zit noch im­pli­zit als Zu­sich­er­ung ei­ner be­stim­mt­en Kurs­ent­wick­lung der ge­nan­nt­en Fi­nanz­in­stru­men­te oder als Handl­ungs­auf­for­der­ung zu ver­steh­en. Der Er­werb von Wert­pa­pier­en birgt Ri­si­ken, die zum To­tal­ver­lust des ein­ge­setz­ten Ka­pi­tals füh­ren kön­nen. Die In­for­ma­tion­en er­setz­en kei­ne, auf die in­di­vi­du­el­len Be­dür­fnis­se aus­ge­rich­te­te, fach­kun­di­ge An­la­ge­be­ra­tung. Ei­ne Haf­tung oder Ga­ran­tie für die Ak­tu­ali­tät, Rich­tig­keit, An­ge­mes­sen­heit und Vol­lständ­ig­keit der zur Ver­fü­gung ge­stel­lt­en In­for­ma­tion­en so­wie für Ver­mö­gens­schä­den wird we­der aus­drück­lich noch stil­lschwei­gend über­nom­men. Die Mar­kets In­side Me­dia GmbH hat auf die ver­öf­fent­lich­ten In­hal­te kei­ner­lei Ein­fluss und vor Ver­öf­fent­lich­ung der Bei­trä­ge kei­ne Ken­nt­nis über In­halt und Ge­gen­stand die­ser. Die Ver­öf­fent­lich­ung der na­ment­lich ge­kenn­zeich­net­en Bei­trä­ge er­folgt ei­gen­ver­ant­wort­lich durch Au­tor­en wie z.B. Gast­kom­men­ta­tor­en, Nach­richt­en­ag­en­tur­en, Un­ter­neh­men. In­fol­ge­des­sen kön­nen die In­hal­te der Bei­trä­ge auch nicht von An­la­ge­in­te­res­sen der Mar­kets In­side Me­dia GmbH und/oder sei­nen Mit­ar­bei­tern oder Or­ga­nen be­stim­mt sein. Die Gast­kom­men­ta­tor­en, Nach­rich­ten­ag­en­tur­en, Un­ter­neh­men ge­hör­en nicht der Re­dak­tion der Mar­kets In­side Me­dia GmbH an. Ihre Mei­nung­en spie­geln nicht not­wen­di­ger­wei­se die Mei­nung­en und Auf­fas­sung­en der Mar­kets In­side Me­dia GmbH und de­ren Mit­ar­bei­ter wie­der. Aus­führ­lich­er Dis­clai­mer